Endocrinologists Weigh in on Steve Jobs' Hormonal Imbalance

January 6, 2009 RSS Feed Print
  • Comment (1)

While Clusterstock asserts that analysts were justified in questioning Apple's Macworld announcement ("this doesn't excuse Apple's failure to be forthright about this critical issue"), the WSJ's Health Blog went as far as to ask endocrinologists what they thought about Steve Jobs' hormonal imbalance. Excerpts:

Michael D. Jensen, an endocrinologist at the Mayo Clinic, suggested that Jobs’s weight loss is probably related to his pancreas.

The pancreas plays a key role in digestion and metabolism. Among other things, the gland located behind the stomach produces insulin and other hormones as well as enzymes the body uses to break down food as it passes through the gut.

In 2004, surgeons removed something called an islet cell neuroendocrine tumor—a rare form of cancer that’s not deadly if caught early — from Jobs’s pancreas. It’s possible that the tumor has recurred, perhaps on the pancreas or the liver, and is upsetting hormonal signals involved in digestion. This might be treated by surgically removing the tumor, or by taking pills that restore the hormonal balance.

That scenario would explain the “hormonal imbalance” Jobs mentioned in his statement, as well as his description of the problem as a “nutritional problem.”

A simpler possibility would be that the tumor removal left Jobs with a pancreas that’s just not big enough to produce enough pancreatic enzymes. In that case, taking the enzymes in pills would be an effective treatment. But if Jobs’s problem were simply that he’s not getting enough enzymes because his pancreas is too small, it wouldn’t typically be referred to as a “hormone imbalance.”

Of course, there are all sorts of other possibilities that have nothing to do with the pancreas. And the vagueness of Jobs’ statement leaves many details unclear. “To an endocrinologist, the most vague statement you can ever make is the term ‘hormone imbalance,’ ” Clay Semenkovich, chief of endocrinology at Washington University in Saint Louis, told us.

Tags:
investing

Reader Comments Read all comments (1)

Add Your Thoughts
Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ.

Stem cells are “non-specialized” cells that have the potential to form into other types of specific cells, such as blood, muscles or nerves. They are unlike "differentiated" cells which have already become whatever organ or structure they are in the body. Stem cells are present throughout our body, but more abundant in a fetus.

Medical researchers and scientists believe that stem cell therapy will, in the near future, advance medicine dramatically and change the course of disease treatment. This is because stem cells have the ability to grow into any kind of cell and, if transplanted into the body, will relocate to the damaged tissue, replacing it. For example, neural cells in the spinal cord, brain, optic nerves, or other parts of the central nervous system that have been injured can be replaced by injected stem cells. Various stem cell therapies are already practiced, a popular one being bone marrow transplants that are used to treat leukemia. In theory and in fact, lifeless cells anywhere in the body, no matter what the cause of the disease or injury, can be replaced with vigorous new cells because of the remarkable plasticity of stem cells. Biomed companies predict that with all of the research activity in stem cell therapy currently being directed toward the technology, a wider range of disease types including cancer, diabetes, spinal cord injury, and even multiple sclerosis will be effectively treated in the future. Recently announced trials are now underway to study both safety and efficacy of autologous stem cell transplantation in MS patients because of promising early results from previous trials.

History

Research into stem cells grew out of the findings of two Canadian researchers, Dr’s James Till and Ernest McCulloch at the University of Toronto in 1961. They were the first to publish their experimental results into the existence of stem cells in a scientific journal. Till and McCulloch documented the way in which embryonic stem cells differentiate themselves to become mature cell tissue. Their discovery opened the door for others to develop the first medical use of stem cells in bone marrow transplantation for leukemia. Over the next 50 years their early work has led to our current state of medical practice where modern science believes that new treatments for chronic diseases including MS, diabetes, spinal cord injuries and many more disease conditions are just around the corner. For more information please visit http://www.neurosurgeonindia.org/

Leo Voisey of AL 7:28AM April 18, 2012

New Money

U.S. News Money takes a contemporary look at happenings in the financial world and aims to help young investors get going with their portfolios--or just sound cool at cocktail parties.

advertisement

advertisement